Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene

被引:33
作者
Bhuju, Sabin [1 ]
Fonseca, Leila de Souza [2 ]
Marsico, Anna Grazia [2 ]
de Oliveira Vieira, Gisele Betzler [2 ]
Sobral, Luciana Fonseca [2 ]
Stehr, Matthias [1 ]
Singh, Mahavir [1 ,3 ]
Feres Saad, Maria Helena [4 ]
机构
[1] Helmholtz Ctr Infect Res, Dept Genome Analyt, Braunschweig, Germany
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil
[3] LIONEX Diagnost & Therapeut GmbH, D-38126 Braunschweig, Germany
[4] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, Rio De Janeiro, Brazil
关键词
Mycobacterium tuberculosis; Tuberculosis; Resistance; pncA gene mutation; Pyrazinamide; PHENOTYPIC CHARACTERIZATION; DRUG-RESISTANCE; SUSCEPTIBILITY; IDENTIFICATION; MECHANISMS; COMPLEX; STRAINS; TESTS;
D O I
10.1016/j.meegid.2013.06.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
It has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is correlated with mutations in the pncA gene. But since years researchers have been puzzled by the fact that up to 30% of PZA resistant strains do not show any correlation between PZA resistance and mutations in the pncA gene, and thus may vary with geographic area. The objective of the study was to investigate the correlation between PZA susceptibility and mutations in pncA gene in M. tuberculosis isolates from individuals living in a highly endemic area. Therefore we analyzed drug resistant and multidrug resistant (MDR) isolates from patients in Rio de Janeiro, Brazil. From a total of 97 clinical isolates of M. tuberculosis 35 were identified as PZA resistant, 24/35 strains did not show PZase activity and 15/24 (62.5%) strains possess mutation in the pncA gene. This is a low correlation between PZA resistance and PZase activity (68.6%) and even lower correlation between PZA resistance and the presence of mutation in pncA gene (45.7%). Most of the mutations found were conserved near the active site or metal binding site of PZase. The 146A > C mutation was found both in PZA resistant and susceptible isolates, suggesting that this mutation may not fully associated with PZA resistance. Of the mutations found, three have not been previously described. The insertions 192-193 TCCTCGTC and 388-389 AGGTCGATG, although found before, here was found to be a short tandem repeat and in one strain, insertion of the IS6110 was observed 55 nt upstream of the gene. All PZA resistant isolates had no mutation in the gene coding ribosomal protein S1 (rpsA), which has recently been proposed as alternate target for pyrazinoic acid (POA). The results show a low association of PZA resistance and pncA gene mutations in a selected patient group from an highly endemic area. Our findings point out that the phenotypic susceptibility testing remains important for the detection of PZA-resistant M. tuberculosis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 46 条
[11]  
Fonseca LD, 2012, J BRAS PNEUMOL, V38, P630, DOI 10.1590/S1806-37132012000500013
[12]   DRUG-RESISTANT TUBERCULOSIS - INCONSISTENT RESULTS OF PYRAZINAMIDE SUSCEPTIBILITY TESTING [J].
HEWLETT, D ;
HORN, DL ;
ALFALLA, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :916-917
[13]   Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis [J].
Hirano, K ;
Takahashi, M ;
Kazumi, Y ;
Fukasawa, Y ;
Abe, C .
TUBERCLE AND LUNG DISEASE, 1998, 78 (02) :117-122
[14]   Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China [J].
Hou, L ;
Osei-Hyiaman, D ;
Zhang, Z ;
Wang, B ;
Yang, A ;
Kano, K .
EPIDEMIOLOGY AND INFECTION, 2000, 124 (02) :227-232
[15]   Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan [J].
Huang, TS ;
Lee, SSJ ;
Tu, HZ ;
Huang, WK ;
Chen, YS ;
Huang, CK ;
Wann, SR ;
Lin, HH ;
Liu, YC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3672-3673
[16]   Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand [J].
Jonmalung, Jirarut ;
Prammananan, Therdsak ;
Leechawengwongs, Manoon ;
Chaiprasert, Angkana .
BMC MICROBIOLOGY, 2010, 10
[17]   Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea [J].
Kim, H. J. ;
Kwak, H. K. ;
Lee, J. ;
Yun, Y. J. ;
Lee, J. S. ;
Lee, M. S. ;
Min, S. Y. ;
Park, S. K. ;
Kang, H. S. ;
Maeng, Y. H. ;
Kim, S. Y. ;
Kim, S. Y. ;
Kook, Y. H. ;
Kim, Y. R. ;
Lee, K. H. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (01) :98-103
[18]   Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea [J].
Lee, KW ;
Lee, JM ;
Jung, KS .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (05) :537-543
[19]   Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA [J].
Lemaitre, N ;
Sougakoff, W ;
Truffot-Pernot, C ;
Jarlier, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1761-1763
[20]  
Louw GE, 2006, INT J TUBERC LUNG D, V10, P802